UnitedHealth’s Q4 EPS Tops Estimates at $2.11 While Peers Face Rising Costs
UnitedHealth reported fourth-quarter 2025 adjusted EPS of $2.11, beating the $2.09 consensus by $0.02. Peer Select Medical saw EPS decline 11.1% to $0.16 on 3.2% higher expenses, underscoring margin pressures across healthcare services.
1. UnitedHealth Q4 Performance
UnitedHealth delivered adjusted EPS of $2.11 in the fourth quarter of 2025, surpassing the consensus estimate of $2.09. Net revenues and segment details were not disclosed, but the $0.02 beat highlights continued earnings resilience.
2. Peer EPS Comparison
Select Medical’s fourth-quarter EPS fell 11.1% year-over-year to $0.16, missing estimates by 31.6%. Net operating revenues rose 6.4% to $1.4 billion, but elevated service costs and lower utilization in key segments weighed on profitability.
3. Industry Margin Pressures
Healthcare services providers faced rising costs of services, with Select Medical’s total expenses up 3.2%. Outpatient Rehabilitation saw a 57.9% EBITDA decline, illustrating broader cost challenges that could pressure insurers’ margins.
4. Implications for UnitedHealth
UnitedHealth’s narrow EPS beat suggests stronger cost management relative to peers, but persistent expense trends in rehabilitation and recovery segments may influence future margin outlook and strategic cost controls.